← Eichor
Condition: Diabetic Neuropathic Pain Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Diabetic Neuropathic Pain

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Phase N/A · 1 location(s) · Brown University · NCT05754190SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
Phase 2 · 7 location(s) · University of Rochester · NCT06614322Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Po
Phase 3 · 15 location(s) · Brainfarma Industria Química e Farmacêutica S/A · NCT07712913Thai PainPREDICT Validation Study
NA · 1 location(s) · Chulalongkorn University · NCT07195045A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · 64 location(s) · Eli Lilly and Company · NCT05986292Normast3 for Adults With Diabetic Polyneuropathy
NA · 1 location(s) · University of Roma La Sapienza · NCT07689214MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts
NA · 1 location(s) · ETH Zurich · NCT05483816Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities
Phase 2 · 1 location(s) · Rigshospitalet, Denmark · NCT05623111Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Phase 3 · 75 location(s) · Vertex Pharmaceuticals Incorporated · NCT07231419Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study
Phase 1/Phase 2 · 1 location(s) · Florida A&M University · NCT07298408Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
NA · 1 location(s) · University of Aarhus · NCT04699734Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Phase 2 · 47 location(s) · Vertex Pharmaceuticals Incorporated · NCT06619860A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2 · 37 location(s) · Eli Lilly and Company · NCT07285018Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
Phase 4 · 1 location(s) · Bangladesh Medical University · NCT07451431Effect of Reiki on Neuropathic Pain Severity and Sleep Quality in Patients With Diabetic Neuropathy
NA · 1 location(s) · TC Erciyes University · NCT06668623Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain
EARLY_Phase 1 · 1 location(s) · Carilion Clinic · NCT07260656Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
Phase 1 · 1 location(s) · Alcamena Stem Cell Therapeutics · NCT07363395Diabetic Neuropathy in Spinal Cord Stimulator Patients
Phase N/A · 1 location(s) · University of Chicago · NCT04687215A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain
Phase 1 · 2 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07377721MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP
Phase 1 · 1 location(s) · Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · NCT06361108High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain
NA · 1 location(s) · Fan BiFa · NCT06158529Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Phase 3 · 76 location(s) · Vertex Pharmaceuticals Incorporated · NCT06628908Neuropathic Pain and Type II Diabetic Patients
Phase N/A · 1 location(s) · Bilecik Seyh Edebali Universitesi · NCT06798181
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.